Table 1.
Primer sequences
| Primer sequences | |
|---|---|
| MiR-378 | Forward: 5’-CTGAGACTGGACTTGGAGTC-3’ |
| Reverse: 5’-GTGCAGGGTCCGAGGT-3’ | |
| U6 | Forward: 5’-TGCGGGTGCTCGCTTCGGCAGC-3’ |
| Reverse: 5’-CCAGTGCAGGGTCCGAGGT-3’ | |
| Bcl-2 | Forward: 5’-CTGTGCTGCTATCCTGC-3’ |
| Reverse: 5’-TGCAGCCACAATACTGT-3’ | |
| Bax | Forward: 5’-CCCGAGAGGTCTTTTTCCGAG-3’ |
| Reverse: 5’-CCAGCCCATGATGGTTCTGAT-3’ | |
| Caspase-3 | Forward: 5’-CCATCCTTCAGTGGTGGACA-3’ |
| Reverse: 5’-TTGAGGCTGCTGCATAATCG-3’ | |
| MAPK1 | Forward: 5’-TCTCCCGCACAAAAATAAGG-3’ |
| Reverse: 5’-GCCAGAGCCTGTTCAACTTC-3’ | |
| GAPDH | Forward: 5’-AAGAAGGTGGTGAAGCAGGC-3’ |
| Reverse: 5’-TCCACCACCCTGTTGCTGTA-3’ |
Note: MiR-378, MicroRNA-378; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X; MAPK1, mitogen-activated protein kinase 1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.